Zhi Tong Cai Jing·2026-02-27 11:47Core Viewpoint - Spring Medical (01858) reported a strong performance for the fiscal year 2025, with total revenue of approximately 1.044 billion yuan, representing a year-on-year growth of 29.52%, and a net profit attributable to shareholders of approximately 272 million yuan, reflecting a significant increase of 117.72% [1] Revenue Growth - The growth in revenue is primarily attributed to the normalization of national procurement for orthopedic consumables, which has led to a steady increase in product sales and an expansion of domestic business scale and market share [1] - The company has successfully leveraged its comprehensive channel coverage and diverse product portfolio to enhance profitability [1] International Expansion - Spring Medical is advancing its international strategy, achieving continuous expansion and breakthroughs in international markets, supported by products that meet international advanced standards in technology and quality [1] - The steady increase in overseas revenue has been a crucial contributor to the overall performance growth of the company [1] Operational Efficiency - The company is focusing on refined operational management and optimizing operational efficiency, which has led to significant improvements in overall operational efficiency and profitability [1] - Through large-scale production, the company has further strengthened its economies of scale, contributing to enhanced operational performance [1]